Kasra Saeb-Parsy

Kasra Saeb-Parsy has worked in a variety of roles in the medical field since 2005. Kasra began as a Research Fellow at the CRUK- Cambridge Research Institute, then moved to a Specialist Registrar in Urology at Cambridge University Hospitals NHS Foundation Trust in 2008. In 2009, they became a Project Board Member and Scientific Advisory Board Member at Cytosystems Ltd. In 2015, they became a Consultant Urologist at the Royal Free London NHS Foundation Trust. In 2016, they became a Consultant Urologist at Nuffield Health and a Partner at CAMBRIDGE UROLOGY PARTNERSHIP LLP. Kasra also became an Honorary Senior Lecturer at Anglia Ruskin University in 2017. In 2018, they became a Consultant Urologist at Genesis CancerCare. In 2021, they became the Chief Medical Officer at FluoretiQ Limited.

Kasra Saeb-Parsy began their education in 1993, when they attended the University of London to pursue a Bachelor of Medicine, Bachelor of Surgery (MBBS) in Medicine. In 1997, they added a Bachelor of Science (B.Sc.) in Molecular Medicine from UCL to their educational credentials, which they completed in 1998.